Neuropsychopharmacology - Table of Contents alert Volume 42 Issue 4

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 42, Issue 4 (March 2017) In this issue Commentary Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Commentary Top Context-Dependent Effects of Inflammation: Reduced Reward Responding is Not an Invariant Outcome of Sickness Michael R Irwin and Naomi I Eisenberger Neuropsychopharmacology 2017 42: 785-786; advance online publication, October 25, 2016; 10.1038/npp.2016.245 Full Text Review Top Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders Rafael T de Sousa, Alexandre A Loch, André F Carvalho, André R Brunoni, Marie Reine Haddad, Ioline D Henter, Carlos A Zarate and Rodrigo Machado-Vieira Neuropsychopharmacology 2017 42: 787-800; advance online publication, August 11, 2016; 10.1038/npp.2016.149 Abstract | Full Text Original Articles Top Lipopolysaccharide Alters Motivated Behavior in a Monetary Reward Task: a Randomized Trial Julie Lasselin, Michael T Treadway, Tamara E Lacourt, Anne Soop, Mats J Olsson, Bianka Karshikoff, Sofie Paues-Göranson, John Axelsson, Robert Dantzer and Mats Lekander Neuropsychopharmacology 2017 42: 801-810; advance online publication, September 13, 2016; 10.1038/npp.2016.191 Abstract | Full Text Genome-Wide Association Study of Loneliness Demonstrates a Role for Common Variation Jianjun Gao, Lea K Davis, Amy B Hart, Sandra Sanchez-Roige, Lide Han, John T Cacioppo and Abraham A Palmer Neuropsychopharmacology 2017 42: 811-821; advance online publication, September 15, 2016; 10.1038/npp.2016.197 Abstract | Full Text How the Brain Wants What the Body Needs: The Neural Basis of Positive Alliesthesia Jason A Avery, Kaiping Burrows, Kara L Kerr, Jerzy Bodurka, Sahib S Khalsa, Martin P Paulus and W Kyle Simmons Neuropsychopharmacology 2017 42: 822-830; advance online publication, July 18, 2016; 10.1038/npp.2016.128 Abstract | Full Text Attenuation of Frontostriatal Connectivity During Reward Processing Predicts Response to Psychotherapy in Major Depressive Disorder Erin Walsh, Hannah Carl, Tory Eisenlohr-Moul, Jared Minkel, Andrew Crowther, Tyler Moore, Devin Gibbs, Chris Petty, Josh Bizzell, Moria J Smoski and Gabriel S Dichter Neuropsychopharmacology 2017 42: 831-843; advance online publication, September 2, 2016; 10.1038/npp.2016.179 Abstract | Full Text Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study OPEN Gerard Sanacora, Michael R Johnson, Arif Khan, Sarah D Atkinson, Robert R Riesenberg, Juan P Schronen, Michael A Burke, John M Zajecka, Luis Barra, Hong-Lin Su, Joel A Posener, Khanh H Bui, Michael C Quirk, Timothy M Piser, Sanjay J Mathew and Sanjeev Pathak Neuropsychopharmacology 2017 42: 844-853; advance online publication, September 29, 2016; 10.1038/npp.2016.224 Abstract | Full Text Histone Lysine Demethylases of JMJD2 or KDM4 Family are Important Epigenetic Regulators in Reward Circuitry in the Etiopathology of Depression Salil Saurav Pathak, Swati Maitra, Sumana Chakravarty and Arvind Kumar Neuropsychopharmacology 2017 42: 854-863; advance online publication, October 6, 2016; 10.1038/npp.2016.231 Abstract | Full Text Identification of MicroRNA-124-3p as a Putative Epigenetic Signature of Major Depressive Disorder Bhaskar Roy, Michael Dunbar, Richard C Shelton and Yogesh Dwivedi Neuropsychopharmacology 2017 42: 864-875; advance online publication, August 31, 2016; 10.1038/npp.2016.175 Abstract | Full Text Tissue Type-Specific Bioenergetic Abnormalities in Adults with Major Depression David G Harper, J Eric Jensen, Caitlin Ravichandran, Roy H Perlis, Maurizio Fava, Perry F Renshaw and Dan V Iosifescu Neuropsychopharmacology 2017 42: 876-885; advance online publication, September 2, 2016; 10.1038/npp.2016.180 Abstract | Full Text TrkB Signaling in Dorsal Raphe Nucleus is Essential for Antidepressant Efficacy and Normal Aggression Behavior Megumi Adachi, Anita E Autry, Melissa Mahgoub, Kanzo Suzuki and Lisa M Monteggia Neuropsychopharmacology 2017 42: 886-894; advance online publication, September 16, 2016; 10.1038/npp.2016.201 Abstract | Full Text β-Adrenergic Receptors Regulate the Acquisition and Consolidation Phases of Aversive Memory Formation Through Distinct, Temporally Regulated Signaling Pathways Hillary C Schiff, Joshua P Johansen, Mian Hou, David E A Bush, Emily K Smith, JoAnna E Klein, Joseph E LeDoux and Robert M Sears Neuropsychopharmacology 2017 42: 895-903; advance online publication, October 20, 2016; 10.1038/npp.2016.238 Abstract | Full Text Involvement of Infralimbic Prefrontal Cortex but not Lateral Habenula in Dopamine Attenuation After Chronic Mild Stress Jared L Moreines, Zoe L Owrutsky and Anthony A Grace Neuropsychopharmacology 2017 42: 904-913; advance online publication, November 4, 2016; 10.1038/npp.2016.249 Abstract | Full Text Hippocampal GABAB(1a) Receptors Constrain Generalized Contextual Fear Joseph F Lynch, Patrick Winiecki, T Lee Gilman, Jordan M Adkins and Aaron M Jasnow Neuropsychopharmacology 2017 42: 914-924; advance online publication, November 11, 2016; 10.1038/npp.2016.255 Abstract | Full Text Associations between Electrophysiological Evidence of Reward and Punishment-Based Learning and Psychotic Experiences and Social Anhedonia in At-Risk Groups Nicole R Karcher, Bruce D Bartholow, Elizabeth A Martin and John G Kerns Neuropsychopharmacology 2017 42: 925-932; advance online publication, September 15, 2016; 10.1038/npp.2016.192 Abstract | Full Text Network-Level Dysconnectivity in Drug-Naïve First-Episode Psychosis: Dissociating Transdiagnostic and Diagnosis-Specific Alterations OPEN Qiyong Gong, Xinyu Hu, William Pettersson-Yeo, Xin Xu, Su Lui, Nicolas Crossley, Min Wu, Hongyan Zhu and Andrea Mechelli Neuropsychopharmacology 2017 42: 933-940; advance online publication, October 26, 2016; 10.1038/npp.2016.247 Abstract | Full Text Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study Euitae Kim, Oliver D Howes, Mattia Veronese, Katherine Beck, Seongho Seo, Jin Woo Park, Jae Sung Lee, Yun-Sang Lee and Jun Soo Kwon Neuropsychopharmacology 2017 42: 941-950; advance online publication, November 18, 2016; 10.1038/npp.2016.258 Abstract | Full Text Clozapine Modulates Glucosylceramide, Clears Aggregated Proteins, and Enhances ATG8/LC3 in Caenorhabditis elegans Limin Hao, Oshrit Ben-David, Suzann M Babb, Anthony H Futerman, Bruce M Cohen and Edgar A Buttner Neuropsychopharmacology 2017 42: 951-962; advance online publication, October 6, 2016; 10.1038/npp.2016.230 Abstract | Full Text Haloperidol Selectively Remodels Striatal Indirect Pathway Circuits Luke E Sebel, Steven M Graves, C Savio Chan and D James Surmeier Neuropsychopharmacology 2017 42: 963-973; advance online publication, August 31, 2016; 10.1038/npp.2016.173 Abstract | Full Text Dysregulation of Striatal Dopamine Receptor Binding in Suicide Megan L Fitzgerald, Suham A Kassir, Mark D Underwood, Mihran J Bakalian, J John Mann and Victoria Arango Neuropsychopharmacology 2017 42: 974-982; advance online publication, July 12, 2016; 10.1038/npp.2016.124 Abstract | Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.